Ovid Therapeutics (OVID) Capital Expenditures Growth (3y) (2019 - 2024)
Ovid Therapeutics (OVID) Capital Expenditures Growth (3y) (2019 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ovid Therapeutics |
311.83 Mn |
156.31 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2024 |
130.85% |
| Jun 30, 2024 |
43.46% |
| Dec 31, 2023 |
-35.57% |
| Sep 30, 2023 |
-33.88% |
| Jun 30, 2023 |
36.23% |
| Mar 31, 2023 |
-57.99% |
| Dec 31, 2022 |
75.30% |
| Sep 30, 2022 |
-1,211.81% |
| Jun 30, 2022 |
846.48% |
| Mar 31, 2022 |
86.64% |
| Sep 30, 2021 |
64.29% |
| Jun 30, 2021 |
-58.92% |
| Dec 31, 2020 |
48.03% |
| Sep 30, 2020 |
54.81% |
| Jun 30, 2020 |
-114.39% |
| Mar 31, 2020 |
67.15% |
| Dec 31, 2019 |
28.73% |
| Sep 30, 2019 |
-80.77% |
| Jun 30, 2019 |
-47.18% |
| Mar 31, 2019 |
-29.90% |
